Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100

Stryker Corporation 8-K filed May 8, 2026

Period ended May 6, 2026 · Filed · accepted 1:02 PM ET · Document on sec.gov · Filing index

5.07 Submission of matters to a vote of security holders

Nothing in this filing raised a red flag, and we have no summary of it. The items it reports are listed above; the document itself is on sec.gov.

Read the filing on sec.gov